secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAXCYTE, INC. (MXCT)
CIK:        0001287098
Form:       8-K
Filed at:   2025-08-11T23:59:59+00:00
Accession:  0001558370-25-011056
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

MaxCyte CCO Ali Soleymannezhad departs effective August 11, 2025; receives nine-month severance
--------------------------------------------------------------------------------

- Ali Soleymannezhad's employment as Chief Commercial Officer ended on August 11, 2025.
- Severance includes base salary for nine months and COBRA contributions during the severance period.
- Severance is contingent on execution and effectiveness of a release of claims and continued compliance.
- No replacement for the Chief Commercial Officer has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1287098/000155837025011056/0001558370-25-011056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1287098/000155837025011056/mxct-20250811x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-011056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer